You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Advanced Malignancies

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Malignant Tumor Trial in Changsha, Chengdu (TQB3912 tablets)

Not yet recruiting
  • Advanced Malignant Neoplasm
  • TQB3912 tablets
  • Changsha, Hunan, China
  • +1 more
Aug 10, 2023

Gastrointestinal Cancer Trial in New York, Providence (Cobimetinib, Hydroxychloroquine, Atezolizumab)

Active, not recruiting
  • Gastrointestinal Cancer
  • New York, New York
  • +1 more
Nov 29, 2022

Advanced or Metastatic Solid Tumors Trial (PRTH-101, Pembrolizumab)

Not yet recruiting
  • Advanced or Metastatic Solid Tumors
  • PRTH-101
  • Pembrolizumab
  • (no location specified)
Feb 27, 2023

Small Cell Lung Cancer, Uveal Melanoma, Ovarian Clear Cell Carcinoma Trial in United States (PLX2853)

Completed
  • Small Cell Lung Cancer
  • +7 more
  • Scottsdale, Arizona
  • +4 more
Jul 20, 2022

Advanced Malignancies Trial in Belgium, Spain, United States (INCA32459-101)

Recruiting
  • Advanced Malignancies
  • Los Angeles, California
  • +14 more
Dec 1, 2022

Advanced Solid Tumor, Lymphoma Trial in Australia, United States (ALPN-202)

Active, not recruiting
  • Advanced Solid Tumor
  • Lymphoma
  • Scottsdale, Arizona
  • +9 more
Nov 8, 2022

Advanced Solid Malignancies Trial in Irving (GIM122)

Not yet recruiting
  • Advanced Solid Malignancies
  • Irving, Texas
    NEXT Dallas
Sep 8, 2023

Cancer, Tumor, Solid, Malignant Tumor Trial (OR502, Cemiplimab)

Not yet recruiting
  • Cancer
  • +6 more
  • (no location specified)
Oct 16, 2023

Melanoma, Non Small Cell Lung Cancer Trial in Moscow, Omsk, Saint Petersburg (BCD-201, Keytruda)

Active, not recruiting
  • Melanoma
  • Non Small Cell Lung Cancer
  • Moscow, Russian Federation
  • +2 more
Feb 13, 2023

Advanced Solid Tumor Trial in Philadelphia (Low dose radiation and ALA)

Recruiting
  • Advanced Solid Tumor
  • Low dose radiation and ALA
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Feb 18, 2022

Advanced Malignancies Trial in Beijing (Recombinant Humanized Monoclonal Antibody MIL95)

Recruiting
  • Advanced Malignancies
  • Recombinant Humanized Monoclonal Antibody MIL95
  • Beijing, China
    Beijing Cancer Hospital
Feb 14, 2022

Advanced Malignancies Trial in Worldwide (Pemigatinib, Retifanlimab, Pembrolizumab)

Recruiting
  • Advanced Malignancies
  • Santa Monica, California
  • +6 more
Apr 6, 2022

Advanced Malignancies Trial in Shanghai (IBI110, IBI110+ Sintilimab)

Recruiting
  • Advanced Malignancies
  • Shanghai, China
    Shanghai Pulmonary Hospital
Sep 13, 2022

Advanced Malignancies Trial in Denmark, Hungary, Russian Federation (BI-1808, Pembrolizumab 25 Mg/mL Solution for Injection)

Recruiting
  • Advanced Malignancies
  • BI-1808
  • Pembrolizumab 25 Mg/mL Solution for Injection
  • Copenhagen, Denmark
  • +11 more
Sep 9, 2022

Advanced Solid Tumor, Non Hodgkin Lymphoma, Acute Myeloid Leukemia Trial in United States (BTX-1188)

Recruiting
  • Advanced Solid Tumor
  • +2 more
  • Duarte, California
  • +3 more
Apr 18, 2022

Malignant Tumor Trial in Los Angeles (biological, drug, other, radiation, procedure)

Active, not recruiting
  • Malignant Neoplasm
  • aldesleukin
  • +7 more
  • Los Angeles, California
    University of California at Los Angeles (UCLA )
Dec 1, 2022

Advanced Solid Tumor Trial in New York, Beijing, Shanghai (NB003 tablets)

Recruiting
  • Advanced Solid Tumor
  • NB003 tablets
  • New York, New York
  • +2 more
Jan 29, 2022

Advanced Solid Malignancies Trial in Chuo-ku, Kashiwa (AZD2014)

Active, not recruiting
  • Advanced Solid Malignancies
  • Chuo-ku, Japan
  • +1 more
Feb 2, 2023

Advanced Cancer, Metastatic Cancer Trial in Spain, United States (FS120)

Recruiting
  • Advanced Cancer
  • Metastatic Cancer
  • New Haven, Connecticut
  • +7 more
Aug 8, 2022

Solid Tumors, Lung Adenocarcinoma, Osteosarcoma Trial in Tianjin (IBI188, GM-CSF, Cisplatin/Carboplatin)

Terminated
  • Solid Tumors
  • +2 more
  • Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Oct 3, 2022

Lymphoma, T-Cell, Cutaneous, Hodgkin Disease, Lymphoma, T-Cell, Peripheral Trial (SGN-35T)

Not yet recruiting
  • Lymphoma, T-Cell, Cutaneous
  • +5 more
  • (no location specified)
Nov 2, 2023

VATS IN PATIENTS WITH ADVANCED OVARIAN MALIGNANCIES

Active, not recruiting
  • Ovarian Cancer
  • VIDEO-ASSISTED THORACOSCOPIC SURGERY
  • Alexandria, Egypt
    Alexandria University
Apr 21, 2023

Advanced Solid Tumors Cancer, Advanced Urothelial Carcinoma, Oral Drug Administration Trial in New York (FX-909)

Not yet recruiting
  • Advanced Solid Tumors Cancer
  • +3 more
  • New York, New York
    Memorial Slone Kettering Cancer Center
Jun 26, 2023

Advanced Malignancies Trial in Worldwide (MBG453, PDR001, Decitabine)

Terminated
  • Advanced Malignancies
  • Baltimore, Maryland
  • +13 more
Sep 20, 2022

Advanced Malignancies Trial in Beijing (IBI322)

Active, not recruiting
  • Advanced Malignancies
  • IBI322
  • Beijing, China
    Cancer hospital Chinese academy of Medical sciences
Sep 15, 2022